• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对五名血细胞比容不同的患者的全血和血浆中环孢素A的评估。

Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits.

作者信息

Agarwal R P, McPherson R A, Threatte G A

出版信息

Ther Drug Monit. 1985;7(1):61-5. doi: 10.1097/00007691-198503000-00010.

DOI:10.1097/00007691-198503000-00010
PMID:3887670
Abstract

Measurement of whole blood and plasma levels of cyclosporin A (CsA) by radioimmunoassay in kidney transplant recipients receiving the drug showed that CsA concentrations in plasma increased nonlinearly when whole blood levels of the drug exceeded 1,000 ng/ml. At low plasma levels (less than 200 ng/ml), most of the CsA in the blood was in the nonplasma component, indicating that cellular elements have high affinity for CsA. Comparison of nonplasma CsA concentrations in two patients with hematocrit values of 32.5 and 35% showed that in the patient with a hematocrit of 35% the cellular associated drug was twice as great as that in the other patient, indicating that there may be significant differences in the cellular affinity of CsA in patients with similar hematocrits. Linear regression analysis of the cellular associated CsA versus plasma levels of the drug in a double-reciprocal plot showed a drug saturation capacity of 6,060 ng/ml in the nonplasma component of blood in the patient with a hematocrit of 35%. Similar analyses in the other patients indicated saturation capacities ranging from 4,750 to 10,400 ng/ml.

摘要

通过放射免疫分析法对接受环孢素A(CsA)治疗的肾移植受者的全血和血浆中环孢素A水平进行测量,结果显示,当全血中环孢素A水平超过1000 ng/ml时,血浆中环孢素A浓度呈非线性增加。在低血浆水平(低于200 ng/ml)时,血液中的大部分环孢素A存在于非血浆成分中,这表明细胞成分对环孢素A具有高亲和力。对两名血细胞比容值分别为32.5%和35%的患者的非血浆环孢素A浓度进行比较,结果显示血细胞比容为35%的患者中与细胞相关的药物是另一名患者的两倍,这表明血细胞比容相似的患者中环孢素A的细胞亲和力可能存在显著差异。在双倒数图中对血细胞比容为35%的患者血液非血浆成分中与细胞相关的环孢素A与药物血浆水平进行线性回归分析,结果显示药物饱和容量为6060 ng/ml。对其他患者进行的类似分析表明,饱和容量范围为4750至10400 ng/ml。

相似文献

1
Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits.对五名血细胞比容不同的患者的全血和血浆中环孢素A的评估。
Ther Drug Monit. 1985;7(1):61-5. doi: 10.1097/00007691-198503000-00010.
2
Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.血细胞比容对肾移植患者全血和血浆中环孢素(环孢素A)的影响。
Clin Chem. 1985 Mar;31(3):410-2.
3
Distribution of cyclosporin A metabolites among plasma and cells in whole blood: effect of temperature, hematocrit, and metabolite concentration.环孢素A代谢产物在全血血浆和细胞中的分布:温度、血细胞比容和代谢产物浓度的影响
Clin Chem. 1989 Jan;35(1):56-63.
4
Monitoring of cyclosporin A levels with radioimmunoassay in renal transplant recipients: comparison of monospecific and nonspecific assays.肾移植受者中环孢素A水平的放射免疫测定监测:单特异性和非特异性测定的比较。
J Formos Med Assoc. 1993 Nov;92(11):948-52.
5
A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.肾移植后环孢素浓度与其治疗效果及毒性关系的前瞻性研究。
Br J Clin Pharmacol. 1990 Sep;30(3):443-52. doi: 10.1111/j.1365-2125.1990.tb03796.x.
6
Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.心脏和肾移植受者血细胞与血浆中环孢素A的分布情况。
Ther Drug Monit. 1988;10(1):28-33.
7
Assessment of variables contributing to cyclosporine distribution in blood.对血液中环孢素分布相关变量的评估。
Ir J Med Sci. 1990 Sep-Dec;159(9-12):269-71. doi: 10.1007/BF02993609.
8
Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.
Ther Drug Monit. 1990 Jul;12(4):344-52. doi: 10.1097/00007691-199007000-00008.
9
Effects of sample preparation on concentrations of cyclosporin A measured in plasma.样品制备对血浆中所测环孢素A浓度的影响。
Clin Chem. 1984 Nov;30(11):1812-4.
10
The influence of haematocrit on blood cyclosporin measurements in vivo.红细胞压积对体内血中环孢素测量的影响。
Br J Clin Pharmacol. 1988 Apr;25(4):509-13. doi: 10.1111/j.1365-2125.1988.tb03336.x.

引用本文的文献

1
The influence of haematocrit on blood cyclosporin measurements in vivo.红细胞压积对体内血中环孢素测量的影响。
Br J Clin Pharmacol. 1988 Apr;25(4):509-13. doi: 10.1111/j.1365-2125.1988.tb03336.x.
2
Adverse reactions and interactions of cyclosporin.环孢素的不良反应及相互作用。
Med Toxicol Adverse Drug Exp. 1988 Mar-Apr;3(2):107-27. doi: 10.1007/BF03259936.
3
Clinical pharmacokinetics in organ transplant patients.器官移植患者的临床药代动力学
Clin Pharmacokinet. 1989 Mar;16(3):134-61. doi: 10.2165/00003088-198916030-00002.
4
Assessment of variables contributing to cyclosporine distribution in blood.对血液中环孢素分布相关变量的评估。
Ir J Med Sci. 1990 Sep-Dec;159(9-12):269-71. doi: 10.1007/BF02993609.
5
Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations.肾移植中急性移植物排斥反应的预测:环孢素血药浓度的作用
Pharm Res. 1991 Feb;8(2):278-81. doi: 10.1023/a:1015820926829.
6
Practical aspects in the use of cyclosporin in paediatric nephrology.环孢素在儿科肾脏病学中应用的实际问题。
Pediatr Nephrol. 1991 Sep;5(5):630-8. doi: 10.1007/BF00856658.
7
Therapeutic monitoring of cyclosporin--an update.
Eur J Clin Pharmacol. 1991;41(4):273-83. doi: 10.1007/BF00314952.